Paylaga, Romel M.

HRN: 25-81-04  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2024
CEFTRIAXONE 1G (VIAL)
09/17/2024
09/24/2024
IV
2g
OD
ANST
Waiting Final Action 
09/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/17/2024
09/24/2024
IV
500mg
Q8hrs
Partial Bowel Obstruction
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: